abstract |
The present invention relates to a pharmaceutical composition containing:(a) a thienopyridine derivative of formula in which R is hydrogen or a (C1-C4)alkoxycarbonyl group, or one of its pharmaceutically acceptable salts; and(b) an HMG-CoA reductase inhibitor. |